Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Improvements in peripheral vascular function with vitamin D treatment in deficient adolescents with type 1 diabetes.

Deda L, Yeshayahu Y, Sud S, Cuerden M, Cherney DZ, Sochett EB, Mahmud FH.

Pediatr Diabetes. 2018 May;19(3):457-463. doi: 10.1111/pedi.12595. Epub 2017 Oct 23.

PMID:
29063654
2.

Technique, Safety, and Yield of Bone Biopsies for Histomorphometry in Children.

Mubarak WM, Pastor C, Gnannt R, Parra DA, Amaral JG, Temple MJ, Sochett EB, Connolly BL.

J Vasc Interv Radiol. 2017 Nov;28(11):1577-1583. doi: 10.1016/j.jvir.2017.07.003. Epub 2017 Aug 18.

PMID:
28827015
3.

Influence of sex on hyperfiltration in patients with uncomplicated type 1 diabetes.

Škrtić M, Lytvyn Y, Bjornstad P, Reich HN, Scholey JW, Yip P, Sochett EB, Perkins B, Cherney DZ.

Am J Physiol Renal Physiol. 2017 Apr 1;312(4):F599-F606. doi: 10.1152/ajprenal.00357.2016. Epub 2016 Dec 28.

4.

The urinary inflammatory profile in gluten free diet-adherent adolescents with type 1 diabetes and celiac disease.

De Melo EN, Deda L, Har R, Reich HN, Scholey JW, Daneman D, Moineddin R, Motran L, Elia Y, Cherney DZ, Sochett EB, Mahmud FH.

J Diabetes Complications. 2016 Mar;30(2):295-9. doi: 10.1016/j.jdiacomp.2015.11.020. Epub 2015 Nov 25.

PMID:
26790575
5.

The urinary cytokine/chemokine signature of renal hyperfiltration in adolescents with type 1 diabetes.

Har RL, Reich HN, Scholey JW, Daneman D, Dunger DB, Moineddin R, Dalton RN, Motran L, Elia Y, Deda L, Ostrovsky M, Sochett EB, Mahmud FH, Cherney DZ.

PLoS One. 2014 Nov 13;9(11):e111131. doi: 10.1371/journal.pone.0111131. eCollection 2014.

6.

Physiological changes in blood pressure impact peripheral endothelial function during adolescence.

Deda L, Sochett EB, Mahmud FH.

Cardiol Young. 2015 Apr;25(4):777-9. doi: 10.1017/S1047951114001024. Epub 2014 Jun 16.

PMID:
24933184
7.

Parathyroid hormone as a functional indicator of vitamin D sufficiency in children.

Maguire JL, Birken C, Thorpe KE, Sochett EB, Parkin PC.

JAMA Pediatr. 2014 Apr;168(4):383-5. doi: 10.1001/jamapediatrics.2013.5379. No abstract available.

PMID:
24535147
8.

The effect of aliskiren on urinary cytokine/chemokine responses to clamped hyperglycaemia in type 1 diabetes.

Cherney DZ, Reich HN, Scholey JW, Daneman D, Mahmud FH, Har RL, Sochett EB.

Diabetologia. 2013 Oct;56(10):2308-17. doi: 10.1007/s00125-013-3000-3. Epub 2013 Jul 28.

PMID:
23893332
9.

The effect of renal hyperfiltration on urinary inflammatory cytokines/chemokines in patients with uncomplicated type 1 diabetes mellitus.

Har R, Scholey JW, Daneman D, Mahmud FH, Dekker R, Lai V, Elia Y, Fritzler ML, Sochett EB, Reich HN, Cherney DZ.

Diabetologia. 2013 May;56(5):1166-73. doi: 10.1007/s00125-013-2857-5. Epub 2013 Feb 15.

PMID:
23412605
10.

A child with autoimmune polyendocrinopathy candidiasis and ectodermal dysplasia treated with immunosuppression: a case report.

O'Gorman CS, Shulman R, Lara-Corrales I, Pope E, Marcon M, Grasemann H, Schneider R, Upton J, Sochett EB, Koltin D, Cohen E.

J Med Case Rep. 2013 Feb 14;7:44. doi: 10.1186/1752-1947-7-44.

11.

Sex differences in renal responses to hyperglycemia, L-arginine, and L-NMMA in humans with uncomplicated type 1 diabetes.

Cherney DZ, Scholey JW, Sochett EB.

Diabetes Care. 2013 May;36(5):1290-6. doi: 10.2337/dc12-1305. Epub 2012 Dec 18.

12.

Hyperfiltration and effect of nitric oxide inhibition on renal and endothelial function in humans with uncomplicated type 1 diabetes mellitus.

Cherney DZ, Reich HN, Jiang S, Har R, Nasrallah R, Hébert RL, Lai V, Scholey JW, Sochett EB.

Am J Physiol Regul Integr Comp Physiol. 2012 Oct 1;303(7):R710-8. doi: 10.1152/ajpregu.00286.2012. Epub 2012 Aug 1.

13.

The effect of direct renin inhibition alone and in combination with ACE inhibition on endothelial function, arterial stiffness, and renal function in type 1 diabetes.

Cherney DZ, Scholey JW, Jiang S, Har R, Lai V, Sochett EB, Reich HN.

Diabetes Care. 2012 Nov;35(11):2324-30. doi: 10.2337/dc12-0773. Epub 2012 Jul 26.

14.

Ability of Cystatin C to detect changes in glomerular filtration rate after ACE inhibition in patients with uncomplicated type 1 diabetes.

Perkins BA, Sochett EB, Cherney DZ.

Clin Exp Hypertens. 2012;34(8):606-11. doi: 10.3109/10641963.2012.681732. Epub 2012 Jun 11.

PMID:
22686422
15.

Vitamin D supplementation and CD4 count in children infected with human immunodeficiency virus.

Kakalia S, Sochett EB, Stephens D, Assor E, Read SE, Bitnun A.

J Pediatr. 2011 Dec;159(6):951-7. doi: 10.1016/j.jpeds.2011.06.010. Epub 2011 Aug 4.

PMID:
21820130
16.

Evolution of renal hyperfiltration and arterial stiffness from adolescence into early adulthood in type 1 diabetes.

Cherney DZ, Sochett EB.

Diabetes Care. 2011 Aug;34(8):1821-6. doi: 10.2337/dc11-0167. Epub 2011 Jun 2.

17.

Ability of cystatin C to detect acute changes in glomerular filtration rate provoked by hyperglycaemia in uncomplicated Type 1 diabetes.

Cherney DZ, Sochett EB, Dekker MG, Perkins BA.

Diabet Med. 2010 Dec;27(12):1358-65. doi: 10.1111/j.1464-5491.2010.03121.x.

PMID:
21059087
18.

Renal hyperfiltration and arterial stiffness in humans with uncomplicated type 1 diabetes.

Cherney DZ, Sochett EB, Lai V, Dekker MG, Slorach C, Scholey JW, Bradley TJ.

Diabetes Care. 2010 Sep;33(9):2068-70. doi: 10.2337/dc10-0767. Epub 2010 Jun 28.

19.

Age is a determinant of acute hemodynamic responses to hyperglycemia and angiotensin II in humans with uncomplicated type 1 diabetes mellitus.

Cherney DZ, Reich HN, Miller JA, Lai V, Zinman B, Dekker MG, Bradley TJ, Scholey JW, Sochett EB.

Am J Physiol Regul Integr Comp Physiol. 2010 Jul;299(1):R206-14. doi: 10.1152/ajpregu.00027.2010. Epub 2010 Apr 21.

20.

Identification of an autoantigen demonstrates a link between interstitial lung disease and a defect in central tolerance.

Shum AK, DeVoss J, Tan CL, Hou Y, Johannes K, O'Gorman CS, Jones KD, Sochett EB, Fong L, Anderson MS.

Sci Transl Med. 2009 Dec 2;1(9):9ra20. doi: 10.1126/scitranslmed.3000284.

21.

Renal hyperfiltration is a determinant of endothelial function responses to cyclooxygenase 2 inhibition in type 1 diabetes.

Cherney DZ, Miller JA, Scholey JW, Nasrallah R, Hébert RL, Dekker MG, Slorach C, Sochett EB, Bradley TJ.

Diabetes Care. 2010 Jun;33(6):1344-6. doi: 10.2337/dc09-2340. Epub 2010 Mar 23.

22.

Case 1: Neonate with seizures and hypocalcemia.

Shulman R, O'Gorman CS, Sochett EB.

Paediatr Child Health. 2008 Mar;13(3):197-200. No abstract available.

23.

Renal hemodynamic effect of cyclooxygenase 2 inhibition in young men and women with uncomplicated type 1 diabetes mellitus.

Cherney DZ, Scholey JW, Nasrallah R, Dekker MG, Slorach C, Bradley TJ, Hébert RL, Sochett EB, Miller JA.

Am J Physiol Renal Physiol. 2008 Jun;294(6):F1336-41. doi: 10.1152/ajprenal.00574.2007. Epub 2008 Apr 9.

24.

The effect of cyclooxygenase-2 inhibition on renal hemodynamic function in humans with type 1 diabetes.

Cherney DZ, Miller JA, Scholey JW, Bradley TJ, Slorach C, Curtis JR, Dekker MG, Nasrallah R, Hébert RL, Sochett EB.

Diabetes. 2008 Mar;57(3):688-95. Epub 2007 Dec 14.

25.

Impact of renin angiotensin system modulation on the hyperfiltration state in type 1 diabetes.

Sochett EB, Cherney DZ, Curtis JR, Dekker MG, Scholey JW, Miller JA.

J Am Soc Nephrol. 2006 Jun;17(6):1703-9. Epub 2006 May 3.

26.

Bone health in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED): findings in 25 adults.

Mäkitie O, Sochett EB, Bondestam S, Sipilä I, Perheentupa J.

Clin Endocrinol (Oxf). 2006 May;64(5):489-94.

PMID:
16649965
27.
28.

Osteoporosis in chronically ill children.

Sochett EB, Mäkitie O.

Ann Med. 2005;37(4):286-94.

PMID:
16019728
29.

Heterozygous mutations in the LDL receptor-related protein 5 (LRP5) gene are associated with primary osteoporosis in children.

Hartikka H, Mäkitie O, Männikkö M, Doria AS, Daneman A, Cole WG, Ala-Kokko L, Sochett EB.

J Bone Miner Res. 2005 May;20(5):783-9. Epub 2005 Jan 4.

30.

Radiographic vertebral morphology: a diagnostic tool in pediatric osteoporosis.

Mäkitie O, Doria AS, Henriques F, Cole WG, Compeyrot S, Silverman E, Laxer R, Daneman A, Sochett EB.

J Pediatr. 2005 Mar;146(3):395-401.

PMID:
15756228
31.

Cardiac and vascular function in adolescents and young adults with type 1 diabetes.

Berger E, Sochett EB, Peirone A, Parikh A, Daneman D.

Diabetes Technol Ther. 2004 Apr;6(2):129-35.

PMID:
15117579
32.

Skeletal phenotype in patients with Shwachman-Diamond syndrome and mutations in SBDS.

Mäkitie O, Ellis L, Durie PR, Morrison JA, Sochett EB, Rommens JM, Cole WG.

Clin Genet. 2004 Feb;65(2):101-12.

PMID:
14984468
33.
34.

Intensive diabetes management decreases Na-Li countertransport in young subjects with type 1 diabetes and enlarged kidneys.

Lawson ML, Sochett EB, Frank MR, Fry MK, Stephens D, Chait P, Daneman D.

J Diabetes Complications. 2000 Nov-Dec;14(6):333-9.

PMID:
11120458
35.

Does dietary protein intake correlate with markers suggestive of early diabetic nephropathy in children and adolescents with Type 1 diabetes mellitus?

O'Hayon BE, Cummings EA, Daneman D, Ossip MG, Lawson ML, Sochett EB.

Diabet Med. 2000 Oct;17(10):708-12.

PMID:
11110503
36.

Carotid artery distensibility and cardiac function in adolescents with type 1 diabetes.

Parikh A, Sochett EB, McCrindle BW, Dipchand A, Daneman A, Daneman D.

J Pediatr. 2000 Oct;137(4):465-9.

PMID:
11035822
37.

Cyclophosphamide and water retention: mechanism revisited.

Campbell DM, Atkinson A, Gillis D, Sochett EB.

J Pediatr Endocrinol Metab. 2000 Jun;13(6):673-5.

PMID:
10905395
38.

Intensive diabetes management in adolescents with type 1 diabetes: the importance of intensive follow-up.

Lawson ML, Frank MR, Fry MK, Perlman K, Sochett EB, Daneman D.

J Pediatr Endocrinol Metab. 2000 Jan;13(1):79-84.

PMID:
10689641
39.

A trial of growth hormone therapy in well-controlled hypophosphataemic rickets.

Cameron FJ, Sochett EB, Daneman A, Kooh SW.

Clin Endocrinol (Oxf). 1999 May;50(5):577-82.

PMID:
10468922
40.

Contribution of growth hormone and IGF-I to early diabetic nephropathy in type 1 diabetes.

Cummings EA, Sochett EB, Dekker MG, Lawson ML, Daneman D.

Diabetes. 1998 Aug;47(8):1341-6.

PMID:
9703337
41.

Frequency and characteristics of lingual thyroid not detected by screening.

Gillis D, Brnjac L, Perlman K, Sochett EB, Daneman D.

J Pediatr Endocrinol Metab. 1998 Mar-Apr;11(2):229-33.

PMID:
9642637
42.

Ambulatory blood pressure monitoring in insulin-dependent diabetes mellitus adolescents with and without microalbuminuria.

Sochett EB, Poon I, Balfe W, Daneman D.

J Diabetes Complications. 1998 Jan-Feb;12(1):18-23.

PMID:
9442810
43.

Urinary growth hormone: a screening test for growth hormone sufficiency.

Butt DA, Sochett EB.

Clin Endocrinol (Oxf). 1997 Oct;47(4):447-54.

PMID:
9404443
44.

Effect of puberty on markers of glomerular hypertrophy and hypertension in IDDM.

Lawson ML, Sochett EB, Chait PG, Balfe JW, Daneman D.

Diabetes. 1996 Jan;45(1):51-5.

PMID:
8522059
45.

Plasma prorenin as an early marker of nephropathy in diabetic (IDDM) adolescents.

Daneman D, Crompton CH, Balfe JW, Sochett EB, Chatzilias A, Cotter BR, Osmond DH.

Kidney Int. 1994 Oct;46(4):1154-9.

46.
47.

Vitamin D status in hospitalized black children under 2 years of age.

Sochett EB, Pettifor JM, Moodley G, Pentopoulos M.

S Afr Med J. 1985 Jun 29;67(26):1041-4.

PMID:
4012477

Supplemental Content

Loading ...
Support Center